Exercise and Inflammation in the Elderly
| Status: | Completed |
|---|---|
| Conditions: | Endocrine |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 45 - 80 |
| Updated: | 6/28/2018 |
| Start Date: | April 1, 2007 |
| End Date: | November 29, 2012 |
Exercise, Inflammation and Pro-thrombotic Modulators in the Elderly
Persistent low-grade inflammation and impaired fibrinolysis, are independent predictors of
several chronic diseases highly prevalent in the older Veteran population including
cardiovascular disease (CVD), stroke, and diabetes. Inflammation is likely to be a causative
underlying mechanism of insulin resistance. Lifestyle changes such as weight loss and
physical activity are advocated for the treatment of these chronic diseases and endpoints,
and data are emerging which suggest that these treatments may be beneficial, in part, due to
their anti-inflammatory effects. Identification of effective therapies that reduce chronic
inflammation for Veterans is important given the widespread adverse health effects of a
chronically elevated inflammatory state.
several chronic diseases highly prevalent in the older Veteran population including
cardiovascular disease (CVD), stroke, and diabetes. Inflammation is likely to be a causative
underlying mechanism of insulin resistance. Lifestyle changes such as weight loss and
physical activity are advocated for the treatment of these chronic diseases and endpoints,
and data are emerging which suggest that these treatments may be beneficial, in part, due to
their anti-inflammatory effects. Identification of effective therapies that reduce chronic
inflammation for Veterans is important given the widespread adverse health effects of a
chronically elevated inflammatory state.
This study will compare the effects of 6 month trial of aerobic exercise (AEX) vs. weight
loss (WL) in older individuals on:
1. adipokine secretion and expression (tumor necrosis factor alpha, adiponectin);
2. adipose tissue and skeletal muscle inflammatory proximal receptor expression
(adiponectin and tumor necrosis factor alpha expression) and signaling pathways; and
3. whether the changes in signal transduction are associated with changes in peripheral
whole body insulin sensitivity by a hyperinsulinemic-euglycemic clamp.
The prevention and treatment of insulin resistance, the metabolic syndrome, and their CVD
complications through exercise and weight loss could improve Veterans' health and reduce
health care costs. Knowledge of their effectiveness has important implications for the
cardiovascular health of Veterans given the widespread adverse health effects of chronic
inflammation on vascular biology, skeletal muscle function and insulin action.
loss (WL) in older individuals on:
1. adipokine secretion and expression (tumor necrosis factor alpha, adiponectin);
2. adipose tissue and skeletal muscle inflammatory proximal receptor expression
(adiponectin and tumor necrosis factor alpha expression) and signaling pathways; and
3. whether the changes in signal transduction are associated with changes in peripheral
whole body insulin sensitivity by a hyperinsulinemic-euglycemic clamp.
The prevention and treatment of insulin resistance, the metabolic syndrome, and their CVD
complications through exercise and weight loss could improve Veterans' health and reduce
health care costs. Knowledge of their effectiveness has important implications for the
cardiovascular health of Veterans given the widespread adverse health effects of chronic
inflammation on vascular biology, skeletal muscle function and insulin action.
Inclusion Criteria:
- Male and Female
- 45-80 yrs of age
- Non-smoking for one year
- Body mass index greater than 20 kg/m2 and less than 50 kg/m2
- Menopause over 1 year
Exclusion Criteria:
- Symptomatic heart disease, coronary artery disease, congestive heart failure, or
uncontrolled hypertension (blood pressure over 180/100 mm Hg) unless medically
stabilized
- Currently being treated for active cancer
- Type 1 diabetes; Insulin or oral agent treatment for diabetes, poorly controlled
diabetes fasting blood glucose over 160 mg/dl
- Allergic to lidocaine
- Untreated dyslipidemia with National Cholesterol Adult Treatment Panel III 10 year
cardiac risk score greater than 10%, or receiving triglyceride lowering meds
- Other systemic disorders that are not medically treated and stable
- Taking beta-blockers, oral steroids, warfarin or any other medications interfering
with fat/muscle metabolism that may not be safely discontinued temporarily for
specific procedures (ie for 72 hours prior)
- Abnormal response to exercise test (ST segment depression greater than 2mm, chest
pain, significant arrhythmias, extreme shortness of breath, cyanosis, exercising BP
above 240/120mm Hg, or other contraindications to exercise) *requires follow up
treatment w/ primary MD for continued participation in study
- Abnormal liver function
- Abnormal renal function
- Chronic pulmonary disease
- Anemia hematocrit below 35 mg/dl, platelets below 100,000/cm3
- Mini-mental state exam below 24, dementia or unstable clinical depression by exam
- Aerobically trained with maximal oxygen consumption greater than 2 standard deviations
above age-adjusted mean
- Exercise group only: History of cerebrovascular disease (by medical history) with
symptoms limiting the ability to exercise
We found this trial at
1
site
Click here to add this to my saved trials
